The Role of Protein Sequence and Amino Acid Composition in Amyloid Formation: Scrambling and Backward Reading of IAPP Amyloid Fibrils

Journal of Molecular Biology

Volumn 404, Issue 2, 2010, Pages 337-352

  Sabaté, Raimon ^a   Espargaró, Alba ^a   de Groot, Natalia S ^b   Valle Delgado, Juan José ^b,c   Fernàndez Busquets, Xavier ^b,c   Ventura, Salvador ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INSTITUTE FOR BIOENGINEERING OF CATALONIA IBEC   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Amyloid formation; Islet amyloid polypeptide; Protein aggregation; Protein sequence; Retro proteins

Indexed keywords

AMYLIN; AMYLOID; AMYLOID BETA PROTEIN; PROTEINASE K;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ARTICLE; CYTOTOXICITY; FIBER; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN POLYMERIZATION; PROTEIN STABILITY; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY;

EID: 78349308081     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2010.09.052     Document Type: Article

References (61)

1. Travaglini-Allocatelli C., Ivarsson Y., Jemth P., Gianni S. Folding and stability of globular proteins and implications for function. Curr. Opin. Struct. Biol. 2009, 19:3-7.
2. Olszewski K.A., Kolinski A., Skolnick J. Does a backwardly read protein sequence have a unique native state?. Protein Eng. 1996, 9:5-14.
3. Guptasarma P. Reversal of peptide backbone direction may result in the mirroring of protein structure. FEBS Lett. 1992, 310:205-210.
4. Lacroix E., Viguera A.R., Serrano L. Reading protein sequences backwards. Fold. Des. 1998, 3:79-85.
5. Fernandez-Busquets X., de Groot N.S., Fernandez D., Ventura S. Recent structural and computational insights into conformational diseases. Curr. Med. Chem. 2008, 15:1336-1349.
6. Chiti F., Dobson C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 2006, 75:333-366.
7. Dobson C.M. Protein folding and misfolding. Nature 2003, 426:884-890.
8. Goldschmidt L., Teng P.K., Riek R., Eisenberg D. Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proc. Natl Acad. Sci. USA 2010, 107:3487-3492.
9. Chiti F., Calamai M., Taddei N., Stefani M., Ramponi G., Dobson C.M. Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proc. Natl Acad. Sci. USA 2002, 99:16419-16426.
10. Ventura S., Zurdo J., Narayanan S., Parreno M., Mangues R., Reif B., et al. Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. Proc. Natl Acad. Sci. USA 2004, 101:7258-7263.
11. Forloni G., Lucca E., Angeretti N., Della Torre P., Salmona M. Amidation of beta-amyloid peptide strongly reduced the amyloidogenic activity without alteration of the neurotoxicity. J. Neurochem. 1997, 69:2048-2054.
12. Selvaggini C., De Gioia L., Cantu L., Ghibaudi E., Diomede L., Passerini F., et al. Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. Biochem. Biophys. Res. Commun. 1993, 194:1380-1386.
13. Ross E.D., Baxa U., Wickner R.B. Scrambled prion domains form prions and amyloid. Mol. Cell. Biol. 2004, 24:7206-7213.
14. Ross E.D., Edskes H.K., Terry M.J., Wickner R.B. Primary sequence independence for prion formation. Proc. Natl Acad. Sci. USA 2005, 102:12825-12830.
15. DuBay K.F., Pawar A.P., Chiti F., Zurdo J., Dobson C.M., Vendruscolo M. Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains. J. Mol. Biol. 2004, 341:1317-1326.
16. Monsellier E., Ramazzotti M., de Laureto P.P., Tartaglia G.G., Taddei N., Fontana A., et al. The distribution of residues in a polypeptide sequence is a determinant of aggregation optimized by evolution. Biophys. J. 2007, 93:4382-4391.
17. Liu Y., Wei H., Wang J., Qu J., Zhao W., Tao H. Effects of randomizing the Sup35NM prion domain sequence on formation of amyloid fibrils in vitro. Biochem. Biophys. Res. Commun. 2007, 353:139-146.
18. Gebre-Medhin S., Olofsson C., Mulder H. Islet amyloid polypeptide in the islets of Langerhans: friend or foe?. Diabetologia 2000, 43:687-695.
19. Clark A., Cooper G.J., Lewis C.E., Morris J.F., Willis A.C., Reid K.B., Turner R.C. Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes. Lancet 1987, 2:231-234.
20. Yoon S., Welsh W.J., Jung H., Yoo Y.D. CSSP2: an improved method for predicting contact-dependent secondary structure propensity. Comput. Biol. Chem. 2007, 31:373-377.
21. Moriarty D.F., Raleigh D.P. Effects of sequential proline substitutions on amyloid formation by human amylin 20-29. Biochemistry 1999, 38:1811-1818.
22. Tracz S.M., Abedini A., Driscoll M., Raleigh D.P. Role of aromatic interactions in amyloid formation by peptides derived from human amylin. Biochemistry 2004, 43:15901-15908.
23. Scrocchi L.A., Ha K., Chen Y., Wu L., Wang F., Fraser P.E. Identification of minimal peptide sequences in the (8-20) domain of human islet amyloid polypeptide involved in fibrillogenesis. J. Struct. Biol. 2003, 141:218-227.
24. Gilead S., Gazit E. The role of the 14-20 domain of the islet amyloid polypeptide in amyloid formation. Exp. Diabetes Res. 2008, 2008:256954.
25. Kajava A.V., Aebi U., Steven A.C. The parallel superpleated beta-structure as a model for amyloid fibrils of human amylin. J. Mol. Biol. 2005, 348:247-252.
26. Luca S., Yau W.M., Leapman R., Tycko R. Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. Biochemistry 2007, 46:13505-13522.
27. Wiltzius J.J., Sievers S.A., Sawaya M.R., Cascio D., Popov D., Riekel C., Eisenberg D. Atomic structure of the cross-beta spine of islet amyloid polypeptide (amylin). Protein Sci. 2008, 17:1467-1474.
28. Fernandez-Escamilla A.M., Rousseau F., Schymkowitz J., Serrano L. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat. Biotechnol. 2004, 22:1302-1306.
29. Tartaglia G.G., Cavalli A., Pellarin R., Caflisch A. Prediction of aggregation rate and aggregation-prone segments in polypeptide sequences. Protein Sci. 2005, 14:2723-2734.
30. Conchillo-Sole O., de Groot N.S., Aviles F.X., Vendrell J., Daura X., Ventura S. AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides. BMC Bioinf. 2007, 8:65.
31. Galzitskaya O.V., Garbuzynskiy S.O., Lobanov M.Y. Prediction of amyloidogenic and disordered regions in protein chains. PLoS Comput. Biol. 2006, 2:e177.
32. Thompson M.J., Sievers S.A., Karanicolas J., Ivanova M.I., Baker D., Eisenberg D. The 3D profile method for identifying fibril-forming segments of proteins. Proc. Natl Acad. Sci. USA 2006, 103:4074-4078.
33. Zhang Z., Chen H., Lai L. Identification of amyloid fibril-forming segments based on structure and residue-based statistical potential. Bioinformatics 2007, 23:2218-2225.
34. Trovato A., Seno F., Tosatto S.C. The PASTA server for protein aggregation prediction. Protein Eng. Des. Sel. 2007, 20:521-523.
35. Jaikaran E.T., Higham C.E., Serpell L.C., Zurdo J., Gross M., Clark A., Fraser P.E. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis. J. Mol. Biol. 2001, 308:515-525.
36. Arimon M., Diez-Perez I., Kogan M.J., Durany N., Giralt E., Sanz F., Fernandez-Busquets X. Fine structure study of Abeta1-42 fibrillogenesis with atomic force microscopy. FASEB J. 2005, 19:1344-1346.
37. Khurana R., Coleman C., Ionescu-Zanetti C., Carter S.A., Krishna V., Grover R.K., et al. Mechanism of thioflavin T binding to amyloid fibrils. J. Struct. Biol. 2005, 151:229-238.
38. Ban T., Yamaguchi K., Goto Y. Direct observation of amyloid fibril growth, propagation, and adaptation. Acc. Chem. Res. 2006, 39:663-670.
39. Jarrett J.T., Lansbury P.T. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?. Cell 1993, 73:1055-1058.
40. Munishkina L.A., Henriques J., Uversky V.N., Fink A.L. Role of protein-water interactions and electrostatics in alpha-synuclein fibril formation. Biochemistry 2004, 43:3289-3300.
41. Scheckel K.G., Sparks D.L. Kinetics of the formation and dissolution of Ni precipitates in a gibbsite/amorphous silica mixture. J. Colloid Interface Sci. 2000, 229:222-229.
42. Krebs M.R., Morozova-Roche L.A., Daniel K., Robinson C.V., Dobson C.M. Observation of sequence specificity in the seeding of protein amyloid fibrils. Protein Sci. 2004, 13:1933-1938.
43. Lorenzo A., Razzaboni B., Weir G.C., Yankner B.A. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 1994, 368:756-760.
44. Bartlett A.I., Radford S.E. An expanding arsenal of experimental methods yields an explosion of insights into protein folding mechanisms. Nat. Struct. Mol. Biol. 2009, 16:582-588.
45. Dill K.A. Theory for the folding and stability of globular proteins. Biochemistry 1985, 24:1501-1509.
46. Fersht A.R. Optimization of rates of protein folding: the nucleation-condensation mechanism and its implications. Proc. Natl Acad. Sci. USA 1995, 92:10869-10873.
47. Dyson H.J., Wright P.E., Scheraga H.A. The role of hydrophobic interactions in initiation and propagation of protein folding. Proc. Natl Acad. Sci. USA 2006, 103:13057-13061.
48. Le Duff C.S., Whittaker S.B., Radford S.E., Moore G.R. Characterisation of the conformational properties of urea-unfolded Im7: implications for the early stages of protein folding. J. Mol. Biol. 2006, 364:824-835.
49. Serio T.R., Cashikar A.G., Kowal A.S., Sawicki G.J., Moslehi J.J., Serpell L., et al. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 2000, 289:1317-1321.
50. Cheon M., Chang I., Mohanty S., Luheshi L.M., Dobson C.M., Vendruscolo M., Favrin G. Structural reorganisation and potential toxicity of oligomeric species formed during the assembly of amyloid fibrils. PLoS Comput. Biol. 2007, 3:1727-1738.
51. Bolognesi B., Kumita J.R., Barros T., Esbjorner-Winters E., Luheshi L., Crowther D.C., et al. ANS binding reveals common features of cytotoxic amyloid species. ACS Chem. Biol. 2010, 5:735-740.
52. Schwartz R., King J. Frequencies of hydrophobic and hydrophilic runs and alternations in proteins of known structure. Protein Sci. 2006, 15:102-112.
53. de la Paz M.L., Serrano L. Sequence determinants of amyloid fibril formation. Proc. Natl Acad. Sci. USA 2004, 101:87-92.
54. West M.W., Wang W., Patterson J., Mancias J.D., Beasley J.R., Hecht M.H. De novo amyloid proteins from designed combinatorial libraries. Proc. Natl Acad. Sci. USA 1999, 96:11211-11216.
55. Wilmot C.M., Thornton J.M. Analysis and prediction of the different types of beta-turn in proteins. J. Mol. Biol. 1988, 203:221-232.
56. Monsellier E., Chiti F. Prevention of amyloid-like aggregation as a driving force of protein evolution. EMBO Rep. 2007, 8:737-742.
57. Tartaglia G.G., Pawar A.P., Campioni S., Dobson C.M., Chiti F., Vendruscolo M. Prediction of aggregation-prone regions in structured proteins. J. Mol. Biol. 2008, 380:425-436.
58. Sawaya M.R., Sambashivan S., Nelson R., Ivanova M.I., Sievers S.A., Apostol M.I., et al. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 2007, 447:453-457.
59. Santoro M.M., Bolen D.W. Unfolding free energy changes determined by the linear extrapolation method: 1. Unfolding of phenylmethanesulfonyl alpha-chymotrypsin using different denaturants. Biochemistry 1988, 27:8063-8068.
60. Sabate R., Gallardo M., Estelrich J. An autocatalytic reaction as a model for the kinetics of the aggregation of beta-amyloid. Biopolymers 2003, 71:190-195.
61. Mauro M., Craparo E.F., Podesta A., Bulone D., Carrotta R., Martorana V., et al. Kinetics of different processes in human insulin amyloid formation. J. Mol. Biol. 2007, 366:258-274.